International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

Nancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg, Ulrich Sack, Torsten Witte, Manfred Herold, Xavier Bossuyt, Lucille Musset, Ricard Cervera, Aresio Plaza-Lopez, Carlos Dias, Maria José Sousa, Antonella Radice, Catharina Eriksson, Olof Hultgren, Markku Viander, Munther Khamashta, Stephan Regenass, Luis Eduardo Coelho Andrade, Allan Wiik & 14 others Angela Tincani, Johan Rönnelid, Donald B. Bloch, Marvin J. Fritzler, Edward K L Chan, I. Garcia-De La Torre, Konstantin N. Konstantinov, Robert Lahita, Merlin Wilson, Olli Vainio, Nicole Fabien, Renato Alberto Sinico, Pierluigi Meroni, Yehuda Shoenfeld

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 ( p

Original languageEnglish
Pages (from-to)17-23
Number of pages7
JournalAnnals of the Rheumatic Diseases
Volume73
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Autoantibodies
Anti-Idiotypic Antibodies
Antigens
Antibodies
Indirect Fluorescent Antibody Technique
Standardization
Assays
Politics
Centers for Disease Control and Prevention (U.S.)
Autoimmunity
Disease control
Autoimmune Diseases
Uncertainty
Arthritis
Testing
Sensitivity and Specificity
DNA
Health

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. / Agmon-Levin, Nancy; Damoiseaux, Jan; Kallenberg, Cees; Sack, Ulrich; Witte, Torsten; Herold, Manfred; Bossuyt, Xavier; Musset, Lucille; Cervera, Ricard; Plaza-Lopez, Aresio; Dias, Carlos; José Sousa, Maria; Radice, Antonella; Eriksson, Catharina; Hultgren, Olof; Viander, Markku; Khamashta, Munther; Regenass, Stephan; Coelho Andrade, Luis Eduardo; Wiik, Allan; Tincani, Angela; Rönnelid, Johan; Bloch, Donald B.; Fritzler, Marvin J.; Chan, Edward K L; Garcia-De La Torre, I.; Konstantinov, Konstantin N.; Lahita, Robert; Wilson, Merlin; Vainio, Olli; Fabien, Nicole; Sinico, Renato Alberto; Meroni, Pierluigi; Shoenfeld, Yehuda.

In: Annals of the Rheumatic Diseases, Vol. 73, No. 1, 01.2014, p. 17-23.

Research output: Contribution to journalArticle

Agmon-Levin, N, Damoiseaux, J, Kallenberg, C, Sack, U, Witte, T, Herold, M, Bossuyt, X, Musset, L, Cervera, R, Plaza-Lopez, A, Dias, C, José Sousa, M, Radice, A, Eriksson, C, Hultgren, O, Viander, M, Khamashta, M, Regenass, S, Coelho Andrade, LE, Wiik, A, Tincani, A, Rönnelid, J, Bloch, DB, Fritzler, MJ, Chan, EKL, Garcia-De La Torre, I, Konstantinov, KN, Lahita, R, Wilson, M, Vainio, O, Fabien, N, Sinico, RA, Meroni, P & Shoenfeld, Y 2014, 'International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies', Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 17-23. https://doi.org/10.1136/annrheumdis-2013-203863
Agmon-Levin, Nancy ; Damoiseaux, Jan ; Kallenberg, Cees ; Sack, Ulrich ; Witte, Torsten ; Herold, Manfred ; Bossuyt, Xavier ; Musset, Lucille ; Cervera, Ricard ; Plaza-Lopez, Aresio ; Dias, Carlos ; José Sousa, Maria ; Radice, Antonella ; Eriksson, Catharina ; Hultgren, Olof ; Viander, Markku ; Khamashta, Munther ; Regenass, Stephan ; Coelho Andrade, Luis Eduardo ; Wiik, Allan ; Tincani, Angela ; Rönnelid, Johan ; Bloch, Donald B. ; Fritzler, Marvin J. ; Chan, Edward K L ; Garcia-De La Torre, I. ; Konstantinov, Konstantin N. ; Lahita, Robert ; Wilson, Merlin ; Vainio, Olli ; Fabien, Nicole ; Sinico, Renato Alberto ; Meroni, Pierluigi ; Shoenfeld, Yehuda. / International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. In: Annals of the Rheumatic Diseases. 2014 ; Vol. 73, No. 1. pp. 17-23.
@article{4d91c166a15a4aab907861fa857e6099,
title = "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies",
abstract = "Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 ( p",
author = "Nancy Agmon-Levin and Jan Damoiseaux and Cees Kallenberg and Ulrich Sack and Torsten Witte and Manfred Herold and Xavier Bossuyt and Lucille Musset and Ricard Cervera and Aresio Plaza-Lopez and Carlos Dias and {Jos{\'e} Sousa}, Maria and Antonella Radice and Catharina Eriksson and Olof Hultgren and Markku Viander and Munther Khamashta and Stephan Regenass and {Coelho Andrade}, {Luis Eduardo} and Allan Wiik and Angela Tincani and Johan R{\"o}nnelid and Bloch, {Donald B.} and Fritzler, {Marvin J.} and Chan, {Edward K L} and {Garcia-De La Torre}, I. and Konstantinov, {Konstantin N.} and Robert Lahita and Merlin Wilson and Olli Vainio and Nicole Fabien and Sinico, {Renato Alberto} and Pierluigi Meroni and Yehuda Shoenfeld",
year = "2014",
month = "1",
doi = "10.1136/annrheumdis-2013-203863",
language = "English",
volume = "73",
pages = "17--23",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

AU - Agmon-Levin, Nancy

AU - Damoiseaux, Jan

AU - Kallenberg, Cees

AU - Sack, Ulrich

AU - Witte, Torsten

AU - Herold, Manfred

AU - Bossuyt, Xavier

AU - Musset, Lucille

AU - Cervera, Ricard

AU - Plaza-Lopez, Aresio

AU - Dias, Carlos

AU - José Sousa, Maria

AU - Radice, Antonella

AU - Eriksson, Catharina

AU - Hultgren, Olof

AU - Viander, Markku

AU - Khamashta, Munther

AU - Regenass, Stephan

AU - Coelho Andrade, Luis Eduardo

AU - Wiik, Allan

AU - Tincani, Angela

AU - Rönnelid, Johan

AU - Bloch, Donald B.

AU - Fritzler, Marvin J.

AU - Chan, Edward K L

AU - Garcia-De La Torre, I.

AU - Konstantinov, Konstantin N.

AU - Lahita, Robert

AU - Wilson, Merlin

AU - Vainio, Olli

AU - Fabien, Nicole

AU - Sinico, Renato Alberto

AU - Meroni, Pierluigi

AU - Shoenfeld, Yehuda

PY - 2014/1

Y1 - 2014/1

N2 - Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 ( p

AB - Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 ( p

UR - http://www.scopus.com/inward/record.url?scp=84889651539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889651539&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2013-203863

DO - 10.1136/annrheumdis-2013-203863

M3 - Article

VL - 73

SP - 17

EP - 23

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -